Fate Therapeutics Inc

FATE

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001434316

SEC filings (opens in a new tab)

In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Fate Therapeutics Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of FATE: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Of which not filed for Q2 2023	Q2 2023	Change
Holders	182	1	188	+7
Shares	112.5M	6.36K	109.1M	−3.34M (−3.0%)
Value	$641.6M	$36.2K	$519.6M	−$122.0M (−19.0%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Fate Therapeutics Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to FATE in Q2 2023
Institution	Shares	Value	% of portfolio
Acadian Asset Management LLC	912,917	$4.34M	0.02%
Healthcare of Ontario Pension Plan Trust Fund	459,038	$2.19M	0.01%
HRT Financial LP	261,611	$1.25M	0.01%
Alpha DNA Investment Management LLC	147,651	$702.8K	0.40%
Graham Capital Management, L.P.	142,401	$677.8K	0.02%
Public Employees Retirement System of Ohio	134,403	$640.0K	0.00%
AE Wealth Management LLC	100,885	$480.2K	0.00%
Mach-1 Financial Group, Inc.	100,869	$480.1K	0.19%
Assenagon Asset Management S.A.	99,842	$475.2K	0.00%
Point72 Middle East FZE	66,080	$314.5K	0.02%
Nebula Research & Development LLC	42,592	$202.7K	0.15%
Engineers Gate Manager LP	38,580	$183.6K	0.01%
Y-Intercept (Hong Kong) Ltd	32,582	$155.1K	0.02%
Cerity Partners LLC	31,950	$152.1K	0.00%
Ergoteles LLC	30,911	$147.1K	0.01%
Franklin Resources Inc	27,096	$129.0K	0.00%
Centiva Capital, LP	24,086	$114.6K	0.01%
American Century Companies Inc	21,214	$101.0K	0.00%
Capstone Investment Advisors, LLC	18,722	$89.1K	0.00%
Laurion Capital Management LP	15,386	$73.2K	0.00%
Mirabella Financial Services LLP	13,467	$64.1K	0.01%
Brown Advisory Inc	12,629	$60.1K	0.00%
Point72 Asset Management, L.P.	10,136	$48.2K	0.00%
Epiq Partners, LLC	10,071	$47.9K	0.03%
Coppell Advisory Solutions LLC	8,865	$42.4K	0.01%
UniSuper Management Pty Ltd	7,350	$35.0K	0.00%
Macroview Investment Management LLC	2,165	$10.3K	0.02%
Huntington National Bank	225	$1.07K	0.00%
Cary Street Partner Investment Advisory LLC	85	$405	0.00%
Baker Avenue Asset Management, LP	46	$219	0.00%
Avion Wealth	96	$0	0.00%

Sold out (24)

Institutions that held Fate Therapeutics Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of FATE in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Artal Group S.A.	2,600,000	$14.8M
AQR Capital Management LLC	271,399	$1.55M
Occudo Quantitative Strategies LP	98,452	$561.2K
Campbell & CO Investment Adviser LLC	59,651	$340.0K
Vident Investment Advisory, LLC	58,045	$330.9K
NinePointTwo Capital	49,325	$281.0K
Aigen Investment Management, LP	35,433	$202.0K
DekaBank Deutsche Girozentrale	30,000	$158.0K
Axq Capital, LP	15,964	$91.0K
Pinnacle Wealth Planning Services, Inc.	13,436	$76.6K
AtonRa Partners	13,035	$74.3K
SG Americas Securities, LLC	11,000	$63.0K
Victory Capital Management Inc	10,228	$58.3K
Advisors Asset Management, Inc.	9,644	$55.0K
Ci Investments Inc.	3,043	$17.0K
Natixis	2,703	$15.4K
Riverview Trust Co	2,497	$14.2K
Lindbrook Capital, LLC	1,407	$8.02K
Baillie Gifford & Co	372	$2.12K
EverSource Wealth Advisors, LLC	325	$1.85K
Itau Unibanco Holding S.A.	226	$1.29K
Steward Partners Investment Advisory, LLC	185	$1.05K
Crewe Advisors LLC	45	$257
ZRC Wealth Management, LLC	27	$154

Not filed for Q2 2023 yet (1)

Institutions that held Fate Therapeutics Inc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FATE in Q1 2023 that haven't filed for Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
ETF Managers Group, LLC	6,359	$36.2K